Tudor Investment Corporation »

Sana Biotechnology shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Sana Biotechnology (SANA) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Sana Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Sana Biotechnology held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sana Biotechnology by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $384k 133k 2.88
2025-06-30 $304k 111k 2.73
2024-06-30 $284k 52k 5.46
2023-09-30 $376k 97k 3.87

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
State Street SPDR S&P 500 ETF Trust - US ETP ETF Option Call Option (SPY)
Spdr Gold Shares - US ETP ETF Option Call Option (GLD)
Nvidia Corp - US Equity (NVDA)
State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Microsoft Corp - US Equity (MSFT)
State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)
Tesla Inc - US Equity (TSLA)
Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)
Meta Platforms Inc - US Equity (META)
Taiwan Semiconductor Manufacturing Co Ltd - US Depository Receipt (TSM)
Alibaba Group Holding Ltd - US Depository Receipt (BABA)
Amazon.Com Inc - US Equity (AMZN)

View all positions for Tudor Investment Corporation

Top funds holding Sana Biotechnology

FMR
Flagship Ventures Management
BlackRock
State Street Corporation
Vanguard Group
Canada Pension Plan Investment Board
Vanguard Capital Management
Baillie Gifford & Co
Geode Capital Management
Marex Group
Integral Health Asset Management
Goldman Sachs Group
Bank of America Corporation
Alphabet
Vanguard Portfolio Management

View all funds holding Sana Biotechnology